KLTO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Klotho Neurosciences Inc (KLTO) is not a suitable buy for a beginner investor with a long-term strategy at this time. The stock shows signs of being overbought based on RSI, lacks positive financial performance, and has no significant trading or news catalysts to support a long-term investment decision. Additionally, there are no proprietary trading signals or options data to indicate a strong trading opportunity.
The MACD histogram is positive at 0.03 and expanding, indicating bullish momentum. However, the RSI is at 82.307, signaling the stock is overbought. Moving averages are converging, and the stock is trading near its resistance level (R1: 0.485). This suggests limited upside potential in the short term.
NULL. No recent news, trading trends, or influential figure activity to act as a positive catalyst.
The stock appears overbought (RSI: 82.307). Financial performance is weak, with declining EPS (-72.22% YoY) and negative net income (-$2,895,585). There are no significant hedge fund or insider trading trends.
In Q3 2025, revenue remained at $0 with no growth. Net income dropped to -$2,895,585 (-2.16% YoY), and EPS declined significantly to -0.05 (-72.22% YoY). Gross margin remained at 0%. Overall, the financials indicate poor performance and no growth.
No data available for analyst ratings or price target changes.
